Not applicableStudy completedNCT01295034What this trial is testingVitamin D Supplements for HIV-positive Patients on cARTWho this might be right forHIV-associated Co-morbidities Andrea Branch 62
Not applicableEnded earlyNCT03473457What this trial is testingCAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia(AML) Zhujiang Hospital 2
Large-scale testing (Phase 3)UnknownNCT04287660What this trial is testingStudy of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) PatientsWho this might be right forMultiple Myeloma The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)WithdrawnNCT03098355What this trial is testingInterleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell MalignanciesWho this might be right forB-Cell LeukemiaB-Cell Lymphoma Zhujiang Hospital
Very early researchTemporarily pausedNCT06586658What this trial is testingAnti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal CellsWho this might be right forRenal Cell Carcinoma Shanghai Changzheng Hospital 9
Very early researchNot Yet RecruitingNCT06097455What this trial is testingFirst in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive LymphomaWho this might be right forRefractory Non-Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma Fundacion Clinic per a la Recerca Biomédica 40
Early research (Phase 1)Looking for participantsNCT06891742What this trial is testingPhase I Study of OriC902 in Treatment of Advanced HCCWho this might be right forHCC Peking University 44
Testing effectiveness (Phase 2)Looking for participantsNCT07153068What this trial is testingSupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesWho this might be right forT Lymphoblastic Leukemia/LymphomaAcute Myeloid Leukemia (AML) Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Looking for participantsNCT07109518What this trial is testingUCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableStudy completedNCT02666248What this trial is testingLong-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer StudiesWho this might be right forSubjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion University of Pennsylvania 3
Not applicableLooking for participantsNCT04914091What this trial is testingQuality Of Life and Drug Use in Patients With CAR-T CellsWho this might be right forPatients With Diffuse Large B-cell Lymphoma Treated With CART-cells Hospices Civils de Lyon 70
Not applicableNot Yet RecruitingNCT06890091What this trial is testingStudy of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's LymphomaWho this might be right forFatigue SymptomLymphoma Non-HodgkinChimeric Antigen Receptor T-cell Therapy+1 more Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Looking for participantsNCT06836505What this trial is testingSafety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.Who this might be right forNeuroblastoma (NB)Desmoplastic Small Round Cell Tumor (DSRCT) Sun Yat-Sen University Cancer Center 10
Testing effectiveness (Phase 2)UnknownNCT04309981What this trial is testingClinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.Who this might be right forRelapsed/Refractory Multiple Myeloma Sara V. Latorre 73
Very early researchStudy completedNCT04652219What this trial is testingCART Therapy in GUCY2C-positive Digestive Tract TumorsWho this might be right forMalignant Neoplasms of Digestive Organs Weijia Fang, MD 1
Not applicableLooking for participantsNCT06333275What this trial is testingRestoration of Immunity to Vaccine Preventable Diseases After CART-T Cell TherapyWho this might be right forVaccine Immunity in CAR-T Cell Therapy Recipients Insel Gruppe AG, University Hospital Bern 80
Not applicableLooking for participantsNCT07309497What this trial is testingPragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)Who this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more University of Zurich 208
Testing effectiveness (Phase 2)Looking for participantsNCT06947460What this trial is testingCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHWho this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06084884What this trial is testingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma AstraZeneca 94
Large-scale testing (Phase 3)Looking for participantsNCT07391657What this trial is testingA Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)Who this might be right forRelapsed Refractory Multiple Myeloma AstraZeneca 508